Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Asian Stocks Up as Omicron Fears Subside

Published 11/30/2021, 10:26 AM
Updated 11/30/2021, 10:26 AM
© Reuters.

© Reuters.

By Gina Lee

Investing.com – Asia Pacific stocks were mostly up on Tuesday morning, ending November on a high note as Chinese data indicated improved factory activity.

China’s Shanghai Composite was up 0.30% by 9:15 PM ET (2:15 AM GMT) and the Shenzhen Component was up 0.21%.

Hong Kong’s Hang Seng Index fell 0.92%.

Japan’s Nikkei 225 rose 0.99%, with October’s employment data showing that the jobs/application ratio was at 1.15 and the unemployment rate was down to 2.7%. Industrial production also grew 1.1% month-on-month.

South Korea’s KOSPI was down 0.52%.

In Australia, the ASX 200 jumped 1.26%, with building approvals contracting 12.9% month-on-month and private sector credit growing 0.5% month-on-month in October. The current account for the third quarter of 2021 stood at AUD23.9 billion ($17.06 billion).

Data released earlier in the day showed that China’s manufacturing purchasing managers index (PMI) was at 50.1, while the non-manufacturing PMI was at 52.3, in November. The Caixin manufacturing and services PMIs are due later in the week.

However, investors also continue to monitor the omricron variant of COVID-19, which is still under evaluation by scientists. U.S. President Joe Biden cautioned against panicking over the new variant and said lockdowns will not be necessary, while pharmaceutical firms such as Moderna (NASDAQ:MRNA) Inc. are already at work adapting vaccines.

“We’ll get a new variant, we’ll get new waves but the market, and we all as investors, see how that might play out,” Thornburg Investment Management president Jason Brady told Bloomberg.

“I’m much more interested in inflation and potentially rising rates causing some of the market leaders of 2020 and 2021 to falter a little bit more.”

The discovery of the new strain has already impacted international travel and could increase inflationary pressures if supply chains are disrupted.

U.S. Federal Reserve Chair Jerome Powell said on Monday that omicron poses risks to both sides of the Fed’s mandate for stable prices and maximum employment. However, he did not specify any actions or indicate an adjustment in the pace of asset tapering.

Powell will testify at a Senate Banking Committee hearing alongside U.S. Treasury Secretary Janet Yellen later in the day. The pair will testify again at the House Financial Services Committee a day later.

Investors also await a slew of U.S. data due throughout the week, beginning with the Conference Board Consumer Confidence index later in the day. The Institute of Supply Management manufacturing PMI, and the Fed Beige Book is due on Wednesday, followed by the U.S. job report, including non-farm payrolls, on Friday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.